{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:40:52Z","timestamp":1761093652657,"version":"build-2065373602"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03219-6","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:42:22Z","timestamp":1761043342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TIGD6 in gastric cancer: exploring its prognostic value and therapeutic potential through molecular and clinical investigations"],"prefix":"10.1186","volume":"30","author":[{"given":"Quanli","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"3219_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051628","author":"S Mantziari","year":"2023","unstructured":"Mantziari S, St Amour P, Abboretti F, Teixeira-Farinha H, Gaspar Figueiredo S, Gronnier C, et al. A comprehensive review of prognostic factors in patients with gastric adenocarcinoma. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15051628.","journal-title":"Cancers"},{"issue":"3","key":"3219_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3219_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101824","volume":"39","author":"B Chen","year":"2024","unstructured":"Chen B, Diallo MT, Ma Y, Yu W, Yao Q, Gao S, et al. Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation. Transl Oncol. 2024;39:101824.","journal-title":"Transl Oncol"},{"issue":"1","key":"3219_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10120-015-0469-0","volume":"19","author":"H Suzuki","year":"2016","unstructured":"Suzuki H, Oda I, Abe S, Sekiguchi M, Mori G, Nonaka S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198\u2013205.","journal-title":"Gastric Cancer"},{"issue":"2","key":"3219_CR5","volume":"1876","author":"K Li","year":"2021","unstructured":"Li K, Zhang A, Li X, Zhang H, Zhao L. Advances in clinical immunotherapy for gastric cancer. Biochim Biophys Acta. 2021;1876(2):188615.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3219_CR6","doi-asserted-by":"publisher","first-page":"19142","DOI":"10.1038\/s41598-024-70184-1","volume":"14","author":"H Liu","year":"2024","unstructured":"Liu H, Dong A, Rasteh AM, Wang P, Weng J. Identification of the novel exhausted T cell CD8 + markers in breast cancer. Sci Rep. 2024;14(1):19142.","journal-title":"Sci Rep"},{"key":"3219_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146325","volume":"822","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J. A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene. 2022;822:146325.","journal-title":"Gene"},{"issue":"3","key":"3219_CR8","first-page":"2140","volume":"15","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. Am J Transl Res. 2023;15(3):2140\u201355.","journal-title":"Am J Transl Res"},{"issue":"5","key":"3219_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10142-024-01443-7","volume":"24","author":"H Liu","year":"2024","unstructured":"Liu H, Weng J, Huang CL, Jackson AP. Is the voltage-gated sodium channel \u03b23 subunit (SCN3B) a biomarker for glioma? Funct Integr Genomics. 2024;24(5):162.","journal-title":"Funct Integr Genomics"},{"key":"3219_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cancergen.2023.03.002","volume":"274\u2013275","author":"H Liu","year":"2023","unstructured":"Liu H. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma. Cancer Genet. 2023;274\u2013275:21\u20135.","journal-title":"Cancer Genet"},{"issue":"3","key":"3219_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/CBM-210340","volume":"34","author":"Y Li","year":"2022","unstructured":"Li Y, Liu H. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma. Cancer Biomark. 2022;34(3):359\u201374.","journal-title":"Cancer Biomark"},{"issue":"4","key":"3219_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/CBM-220143","volume":"35","author":"H Liu","year":"2022","unstructured":"Liu H, Li Y. Potential roles of Cornichon Family AMPA Receptor Auxiliary Protein 4 (CNIH4) in head and neck squamous cell carcinoma. Cancer Biomark. 2022;35(4):439\u201350.","journal-title":"Cancer Biomark"},{"issue":"17","key":"3219_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, Zou Y, Jia J, Li H, et al. Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon. 2024;10(17):e37046.","journal-title":"Heliyon"},{"issue":"2","key":"3219_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3668","volume":"26","author":"Q Li","year":"2024","unstructured":"Li Q, Chu Y, Yao Y, Song Q. A treg-related risk score model may improve the prognosis evaluation of colorectal cancer. J Gene Med. 2024;26(2):e3668.","journal-title":"J Gene Med"},{"issue":"2","key":"3219_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/0109298665350171241204153202","volume":"32","author":"G Lyu","year":"2025","unstructured":"Lyu G, Li D. Zp3 expression in pancreatic adenocarcinoma: its implications for the prognosis and therapy. Protein Pept Lett. 2025;32(2):124\u201338.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"3219_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0314745","volume":"20","author":"H Liu","year":"2025","unstructured":"Liu H, Karsidag M, Chhatwal K, Wang P, Tang T. Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoS ONE. 2025;20(1):e0314745.","journal-title":"PLoS ONE"},{"issue":"8","key":"3219_CR17","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H. Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res. 2022;12(8):4074\u201381.","journal-title":"Am J Cancer Res"},{"key":"3219_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108302","volume":"240","author":"H Liu","year":"2022","unstructured":"Liu H, Dilger JP, Lin J. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacol Ther. 2022;240:108302.","journal-title":"Pharmacol Ther"},{"key":"3219_CR19","first-page":"3","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark. 2024;41:3\u20134.","journal-title":"Cancer Biomark"},{"key":"3219_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858756","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J. A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction. Front Oncol. 2022;12:858756.","journal-title":"Front Oncol"},{"key":"3219_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103.","journal-title":"Cancer Genet"},{"issue":"10","key":"3219_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/crj.70023","volume":"18","author":"Y Ye","year":"2024","unstructured":"Ye Y, Long F, Yue W, Wei Z, Yang J, Xie Y. Unveiling the enigmatic role of SLC35F3 in lung adenocarcinoma. Clin Respir J. 2024;18(10):e70023.","journal-title":"Clin Respir J"},{"key":"3219_CR23","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2147\/JIR.S448091","volume":"17","author":"J He","year":"2024","unstructured":"He J, Jing D, Zhao S, Duan M. BAP31 promotes adhesion between endothelial cells and macrophages through the NF-\u03baB signaling pathway in sepsis. J Inflamm Res. 2024;17:1267\u201379.","journal-title":"J Inflamm Res"},{"key":"3219_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.756094","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Gu W, Wen W, Zhang X. SERPINH1 is a potential prognostic biomarker and correlated with immune infiltration: a pan-cancer analysis. Front Genet. 2021;12:756094.","journal-title":"Front Genet"},{"issue":"24","key":"3219_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246220","volume":"14","author":"D Yang","year":"2022","unstructured":"Yang D, Liu M, Jiang J, Luo Y, Wang Y, Chen H, et al. Comprehensive analysis of DMRT3 as a potential biomarker associated with the immune infiltration in a pan-cancer analysis and validation in lung adenocarcinoma. Cancers. 2022;14(24):6220.","journal-title":"Cancers"},{"key":"3219_CR26","volume":"27","author":"W Yi","year":"2021","unstructured":"Yi W, Shen H, Sun D, Xu Y, Feng Y, Li D, et al. Low expression of long noncoding RNA SLC26A4 antisense RNA 1 Is an independent prognostic biomarker and correlate of immune infiltrates in breast cancer. Med Sci Monit: Int Med J Exp Clin Res. 2021;27:e934522.","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"key":"3219_CR27","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2174\/0115665240260252230919054858","volume":"24","author":"L Miao","year":"2023","unstructured":"Miao L, Jing L, Chen B, Zeng T, Chen Y. TPD52 is a potential prognostic biomarker and correlated with immune infiltration: a pan-cancer analysis. Curr Mol Med. 2023;24:1413.","journal-title":"Curr Mol Med"},{"key":"3219_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1574892818666230111115040","volume":"19","author":"L Miao","year":"2024","unstructured":"Miao L, Chen B, Jing L, Zeng T, Chen Y. TPD52 as a potential prognostic biomarker and its correlation with immune infiltrates in uterine corpus endometrial carcinoma: bioinformatic analysis and experimental verification. Recent Pat Anti-Cancer Drug Discov. 2024;19:1\u201318.","journal-title":"Recent Pat Anti-Cancer Drug Discov"},{"issue":"1","key":"3219_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40659-021-00340-8","volume":"54","author":"L Wang","year":"2021","unstructured":"Wang L, Gao S. Identification of 5-methylcytosine-related signature for predicting prognosis in ovarian cancer. Biol Res. 2021;54(1):18.","journal-title":"Biol Res"},{"issue":"2","key":"3219_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/mc.23655","volume":"63","author":"M Cheng","year":"2024","unstructured":"Cheng M, Liu L, Zeng Y, Li Z, Zhang T, Xu R, et al. An inflammatory gene-related prognostic risk score model for prognosis and immune infiltration in glioblastoma. Mol Carcinog. 2024;63(2):326\u201338.","journal-title":"Mol Carcinog"},{"issue":"1","key":"3219_CR31","doi-asserted-by":"publisher","first-page":"2255369","DOI":"10.1080\/15384047.2023.2255369","volume":"24","author":"S Cong","year":"2023","unstructured":"Cong S, Bai S, Zhang M, Bi Y, Wang Y, Jin S, et al. A study on metabolic characteristics and metabolic markers of gastrointestinal tumors. Cancer Biol Ther. 2023;24(1):2255369.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"3219_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"3219_CR33","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.7150\/jca.68673","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang K, Yu X, Chen M, Du Y. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker endothelin receptor type A in stomach adenocarcinoma. J Cancer. 2022;13(7):2086\u2013104.","journal-title":"J Cancer"},{"issue":"17","key":"3219_CR34","doi-asserted-by":"publisher","first-page":"12392","DOI":"10.18632\/aging.206096","volume":"16","author":"S Xing","year":"2024","unstructured":"Xing S, Li D, Zhao Q. RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2\/P53 signaling pathway. Aging. 2024;16(17):12392\u2013413.","journal-title":"Aging"},{"key":"3219_CR35","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.2147\/IJGM.S335821","volume":"14","author":"H Pan","year":"2021","unstructured":"Pan H, Liu Q, Zhang F, Wang X, Wang S, Shi X. High STK40 expression as an independent prognostic biomarker and correlated with immune infiltrates in low-grade gliomas. Int J Gen Med. 2021;14:6389\u2013400.","journal-title":"Int J Gen Med"},{"key":"3219_CR36","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.2147\/IJGM.S326402","volume":"14","author":"J Chen","year":"2021","unstructured":"Chen J, Tang H, Li T, Jiang K, Zhong H, Wu Y, et al. Comprehensive analysis of the expression, prognosis, and biological significance of OVOLs in breast cancer. Int J Gen Med. 2021;14:3951\u201360.","journal-title":"Int J Gen Med"},{"key":"3219_CR37","doi-asserted-by":"crossref","unstructured":"Zhang J, Kuang P, Wan F, Zhang Y, Zhang W, Zhang X. Effects of CLDN9 on Proliferation of Uterine Corpus Endometrioid Carcinoma Cells. InProceedings of the 2023 15th International Conference on Bioinformatics and Biomedical Technology. 2023. p. 136\u201342","DOI":"10.1145\/3608164.3608183"},{"issue":"16","key":"3219_CR38","doi-asserted-by":"publisher","first-page":"14657","DOI":"10.1007\/s00432-023-05257-1","volume":"149","author":"Y Chen","year":"2023","unstructured":"Chen Y, Xu H, Tang H, Li H, Zhang C, Jin S, et al. Mir-9-5p expression is associated with vascular invasion and prognosis in hepatocellular carcinoma, and in vitro verification. J Cancer Res Clin Oncol. 2023;149(16):14657\u201371.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3219_CR39","doi-asserted-by":"publisher","DOI":"10.2174\/0115748928344326240927071620","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li D, Fang Y. Unveiling miR-1468-5p: a new prognostic biomarker and therapeutic target in lung adenocarcinoma. Recent Pat Anti-Cancer Drug Discov. 2025. https:\/\/doi.org\/10.2174\/0115748928344326240927071620.","journal-title":"Recent Pat Anti-Cancer Drug Discov"},{"key":"3219_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.730847","volume":"12","author":"W Xiao","year":"2021","unstructured":"Xiao W, Cao RC, Yang WJ, Tan JH, Liu RQ, Kan HP, et al. Roles and clinical significances of ATF6, EMC6, and APAF1 in prognosis of pancreatic cancer. Front Genet. 2021;12:730847.","journal-title":"Front Genet"},{"key":"3219_CR41","first-page":"985","volume":"15","author":"W Liang","year":"2022","unstructured":"Liang W, Lu Y, Pan X, Zeng Y, Zheng W, Li Y, et al. Decreased expression of a novel lncRNA FAM181A-AS1 is associated with poor prognosis and immune infiltration in lung adenocarcinoma. Pharmacogen Personal Med. 2022;15:985\u201398.","journal-title":"Pharmacogen Personal Med"},{"issue":"22","key":"3219_CR42","doi-asserted-by":"publisher","first-page":"13041","DOI":"10.18632\/aging.205218","volume":"15","author":"H Cai","year":"2023","unstructured":"Cai H, Chen S, Wu Z, Wang F, Tang S, Li D, et al. Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma. Aging. 2023;15(22):13041\u201358.","journal-title":"Aging"},{"key":"3219_CR43","doi-asserted-by":"publisher","first-page":"8541","DOI":"10.2147\/IJGM.S340683","volume":"14","author":"Z Lin","year":"2021","unstructured":"Lin Z, Huang W, Yi Y, Li D, Xie Z, Li Z, et al. LncRNA ADAMTS9-AS2 is a prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma. Int J Gen Med. 2021;14:8541\u201355.","journal-title":"Int J Gen Med"},{"issue":"2","key":"3219_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114292","volume":"444","author":"K Huang","year":"2025","unstructured":"Huang K, Wu L, Xu D, Zhang H, Liu Q, Xie Y. Downregulation of CTRP1 reduces radio-resistance in glioblastoma cells by inhibiting the expression of CD133 after X-ray and carbon ion irradiation. Exp Cell Res. 2025;444(2):114292.","journal-title":"Exp Cell Res"},{"issue":"1","key":"3219_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10565-024-09878-1","volume":"40","author":"CY Wang","year":"2024","unstructured":"Wang CY, Li MY, Li SY, Wei XG, Yuan ZW, Tang XB, et al. Spatial transcriptomics reveals gene interactions and signaling pathway dynamics in rat embryos with anorectal malformation. Cell Biol Toxicol. 2024;40(1):34.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"3219_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2425134","volume":"25","author":"Y Jia","year":"2024","unstructured":"Jia Y, Liu M, Liu H, Liang W, Zhu Q, Wang C, et al. DSN1 may predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy. Cancer Biol Ther. 2024;25(1):2425134.","journal-title":"Cancer Biol Ther"},{"key":"3219_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.842351","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xu L, Feng J, Tan D, Zhu Y, Hou J, et al. ASF1B is a promising prognostic biomarker and correlates with immunotherapy efficacy in hepatocellular carcinoma. Front Genet. 2022;13:842351.","journal-title":"Front Genet"},{"issue":"4","key":"3219_CR48","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"key":"3219_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417203","author":"T Liu","year":"2023","unstructured":"Liu T, Wu H, Wei J. The construction and validation of a novel ferroptosis-related gene signature in Parkinson\u2019s disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242417203.","journal-title":"Int J Mol Sci"},{"key":"3219_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1267629","volume":"13","author":"H Yuan","year":"2023","unstructured":"Yuan H, Jiang T, Zhang WD, Yang Z, Luo S, Wang X, et al. Multiomics and bioinformatics identify differentially expressed effectors in the brain of Toxoplasma gondii infected masked palm civet. Front Cell Infect Microbiol. 2023;13:1267629.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"3219_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290031","volume":"18","author":"B Chen","year":"2023","unstructured":"Chen B, Lu X, Zhou Q, Chen Q, Zhu S, Li G, et al. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer. PLoS ONE. 2023;18(8):e0290031.","journal-title":"PLoS ONE"},{"issue":"50","key":"3219_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036480","volume":"102","author":"ZM Lu","year":"2023","unstructured":"Lu ZM, Pan SL, Yuan WL, Feng JL, Tian D, Shang XQ. Molecular and immunological characteristics of patients with CMTM6 low expression colorectal cancer. Medicine (Baltimore). 2023;102(50):e36480.","journal-title":"Medicine (Baltimore)"},{"key":"3219_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2023.116967","volume":"202","author":"Q Du","year":"2023","unstructured":"Du Q, Xing N, Guo S, Meng X, Zhang Y, Wang S. Cycas revoluta leaves: as a potential flavonoids source for targeted regulation of immune-related markers in lung adenocarcinoma. Ind Crop Prod. 2023;202:116967.","journal-title":"Ind Crop Prod"},{"key":"3219_CR54","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"1","key":"3219_CR55","doi-asserted-by":"publisher","first-page":"21233","DOI":"10.1038\/s41598-024-72387-y","volume":"14","author":"J Yao","year":"2024","unstructured":"Yao J, Ma F, Shi D, Da M. ZFP1 is a biomarker related to poor prognosis and immunity in gastric cancer. Sci Rep. 2024;14(1):21233.","journal-title":"Sci Rep"},{"key":"3219_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1043512","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Zhao Z, Zhang Y, Liang W, Zhou C, Lin W, et al. Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma. Front Immunol. 2022;13:1043512.","journal-title":"Front Immunol"},{"issue":"1","key":"3219_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42171-5","volume":"13","author":"B Chen","year":"2023","unstructured":"Chen B, Ding X, Wan A, Qi X, Lin X, Wang H, et al. Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer. Sci Rep. 2023;13(1):16244.","journal-title":"Sci Rep"},{"key":"3219_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.656509","volume":"11","author":"M Chen","year":"2021","unstructured":"Chen M, Li S, Liang Y, Zhang Y, Luo D, Wang W. Integrative multi-omics analysis of identified NUF2 as a candidate oncogene correlates with poor prognosis and immune infiltration in non-small cell lung cancer. Front Oncol. 2021;11:656509.","journal-title":"Front Oncol"},{"issue":"1","key":"3219_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36586-3","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gu X, Zhu F, Li Y, Huang Y, Ju S. High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells. Sci Rep. 2023;13(1):9360.","journal-title":"Sci Rep"},{"issue":"16","key":"3219_CR60","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1093\/hmg\/ddw199","volume":"25","author":"P Jiang","year":"2016","unstructured":"Jiang P, Liang M, Zhang C, Zhao X, He Q, Cui L, et al. Biochemical evidence for a mitochondrial genetic modifier in the phenotypic manifestation of Leber\u2019s hereditary optic neuropathy-associated mitochondrial DNA mutation. Hum Mol Genet. 2016;25(16):3613\u201325.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3219_CR61","doi-asserted-by":"publisher","first-page":"17350","DOI":"10.1038\/s41598-023-44143-1","volume":"13","author":"L Li","year":"2023","unstructured":"Li L, Tang C, Ye J, Xu D, Chu C, Wang L, et al. Bioinformatic analysis of m6A \u201creader\u201d YTH family in pan-cancer as a clinical prognosis biomarker. Sci Rep. 2023;13(1):17350.","journal-title":"Sci Rep"},{"issue":"1","key":"3219_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40659-020-00314-2","volume":"53","author":"H Wang","year":"2020","unstructured":"Wang H, Chong T, Li B-Y, Chen X-S, Zhen W-B. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer. Biol Res. 2020;53(1):46.","journal-title":"Biol Res"},{"issue":"6","key":"3219_CR63","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10565-021-09643-8","volume":"38","author":"R Yang","year":"2022","unstructured":"Yang R, Liu Z, Cao H, Shi Y. LINC01089, suppressed by YY1, inhibits lung cancer progression by targeting miR-301b-3p\/HPDG axis. Cell Biol Toxicol. 2022;38(6):1063\u201377.","journal-title":"Cell Biol Toxicol"},{"issue":"12","key":"3219_CR64","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1111\/jcmm.13239","volume":"21","author":"W Weng","year":"2017","unstructured":"Weng W, Ni S, Wang Y, Xu M, Zhang Q, Yang Y, et al. PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis. J Cell Mol Med. 2017;21(12):3360\u201371.","journal-title":"J Cell Mol Med"},{"key":"3219_CR65","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/DDDT.S244462","volume":"14","author":"Y Jia","year":"2020","unstructured":"Jia Y, He W, Zhang H, He L, Wang Y, Zhang T, et al. Morusin ameliorates IL-1\u03b2-induced chondrocyte inflammation and osteoarthritis via NF-\u03baB signal pathway. Drug Des Dev Ther. 2020;14:1227\u201340.","journal-title":"Drug Des Dev Ther"},{"key":"3219_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00514","volume":"7","author":"Q Pan","year":"2017","unstructured":"Pan Q, Zhang Q, Chu J, Pais R, Liu S, He C, et al. Chlamydia abortus Pmp18.1 induces IL-1\u03b2 secretion by TLR4 activation through the MyD88, NF-\u03baB, and Caspase-1 signaling pathways. Front Cell Infect Microbiol. 2017;7:514.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"3219_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02126-x","volume":"23","author":"G Lin","year":"2025","unstructured":"Lin G, Liu Q, Xie C, Ding K, Mo G, Zeng L, et al. Upregulated FSP1 by GPD1\/1L mediated lipid droplet accumulation enhances ferroptosis resistance and peritoneal metastasis in gastric cancer. Cell Commun Signal. 2025;23(1):132.","journal-title":"Cell Commun Signal"},{"issue":"18","key":"3219_CR68","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.7150\/jca.101901","volume":"15","author":"Z Yin","year":"2024","unstructured":"Yin Z, Tao J, Liu Y, Chen H, Hu K, Wang Y, et al. In silico analysis uncovers FOXA1 as a potential biomarker for predicting neoadjuvant chemotherapy response in fine-needle aspiration biopsies. J Cancer. 2024;15(18):6052\u201372.","journal-title":"J Cancer"},{"issue":"2","key":"3219_CR69","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3892\/mmr.2020.11158","volume":"22","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhang K, Hou Y. Long non-coding RNA NNT-AS1 knockdown represses the progression of gastric cancer via modulating the miR-142-5p\/SOX4\/Wnt\/\u03b2-catenin signaling pathway. Mol Med Rep. 2020;22(2):687\u201396.","journal-title":"Mol Med Rep"},{"key":"3219_CR70","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3389\/fonc.2019.01544","volume":"9","author":"M Wu","year":"2019","unstructured":"Wu M, Ding Y, Jiang X, Chen Y, Wu N, Li L, et al. Overexpressed MAGP1 Is associated with a poor prognosis and promotes cell migration and invasion in gastric cancer. Front Oncol. 2019;9:1544.","journal-title":"Front Oncol"},{"issue":"1","key":"3219_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03755-5","volume":"25","author":"D Zhou","year":"2025","unstructured":"Zhou D, Cui Y, Liang T, Wu Z, Yan H, Li Y, et al. Pan-cancer analysis identifies CLEC12A as a potential biomarker and therapeutic target for lung adenocarcinoma. Cancer Cell Int. 2025;25(1):128.","journal-title":"Cancer Cell Int"},{"key":"3219_CR72","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/JHC.S337111","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu X, Zhang Y, Wang Z, Liu L, Zhang G, Li J, et al. PRRC2A promotes hepatocellular carcinoma progression and associates with immune infiltration. J Hepatocell Carcinoma. 2021;8:1495\u2013511.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"3219_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113176","volume":"417","author":"F Luo","year":"2022","unstructured":"Luo F, Lin K. N(6)-methyladenosine (m(6)A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner. Exp Cell Res. 2022;417(1):113176.","journal-title":"Exp Cell Res"},{"issue":"3","key":"3219_CR74","first-page":"1501","volume":"19","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang B, Zhao J, Yu X, Liu X, Zhang L, et al. Epithelial-mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells. Mol Med Rep. 2019;19(3):1501\u20138.","journal-title":"Mol Med Rep"},{"issue":"13","key":"3219_CR75","doi-asserted-by":"publisher","first-page":"15577","DOI":"10.18632\/oncotarget.6402","volume":"7","author":"K Chandran","year":"2016","unstructured":"Chandran K, Goswami S, Sharma-Walia N. Implications of a peroxisome proliferator-activated receptor alpha (PPAR\u03b1) ligand clofibrate in breast cancer. Oncotarget. 2016;7(13):15577\u201399.","journal-title":"Oncotarget"},{"issue":"9","key":"3219_CR76","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00198-020-05438-5","volume":"31","author":"DE Whittier","year":"2020","unstructured":"Whittier DE, Boyd SK, Burghardt AJ, Paccou J, Ghasem-Zadeh A, Chapurlat R, et al. Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography. Osteoporos Int. 2020;31(9):1607\u201327.","journal-title":"Osteoporos Int"},{"issue":"6","key":"3219_CR77","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/cancers14061385","volume":"14","author":"X Xing","year":"2022","unstructured":"Xing X, Mu N, Yuan X, Wang N, Juhlin CC, Str\u00e5\u00e5t K, et al. Downregulation and hypermethylation of GABPB1 is associated with aggressive thyroid cancer features. Cancers. 2022;14(6):1385.","journal-title":"Cancers"},{"issue":"19","key":"3219_CR78","doi-asserted-by":"publisher","first-page":"23262","DOI":"10.18632\/aging.203618","volume":"13","author":"Y Yang","year":"2021","unstructured":"Yang Y, Gu X, Li Z, Zheng C, Wang Z, Zhou M, et al. Whole-exome sequencing of rectal cancer identifies locally recurrent mutations in the Wnt pathway. Aging. 2021;13(19):23262\u201383.","journal-title":"Aging"},{"key":"3219_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1036356","author":"W He","year":"2023","unstructured":"He W, Dong S, Shen J, Wu J, Zhao P, Li D, et al. Whole-genome sequencing identified novel mutations in a Chinese family with lynch syndrome. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1036356.","journal-title":"Front Oncol"},{"issue":"9","key":"3219_CR80","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/mc.23566","volume":"62","author":"J Wang","year":"2023","unstructured":"Wang J, Cheng Z, Dai D, Li H, Shao X, Xu M. Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT-mTOR pathway. Mol Carcinog. 2023;62(9):1325\u201337.","journal-title":"Mol Carcinog"},{"issue":"1","key":"3219_CR81","doi-asserted-by":"publisher","first-page":"8305","DOI":"10.1038\/s41598-025-93124-z","volume":"15","author":"R Wu","year":"2025","unstructured":"Wu R, Guo Y, Chen Y, Zhang J. Osteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease study 2021. Sci Rep. 2025;15(1):8305.","journal-title":"Sci Rep"},{"issue":"21","key":"3219_CR82","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.3889\/oamjms.2019.850","volume":"7","author":"SP Pasaribu","year":"2019","unstructured":"Pasaribu SP, Kaban J, Ginting M, Silalahi J. Preparation of in situ cross-linked N-maleoyl chitosan-oxidized sodium alginate hydrogels for drug delivery applications. Open Access Maced J Med Sci. 2019;7(21):3546\u201353.","journal-title":"Open Access Maced J Med Sci"},{"key":"3219_CR83","doi-asserted-by":"publisher","first-page":"1560095","DOI":"10.3389\/fcell.2025.1560095","volume":"13","author":"Y Hong","year":"2025","unstructured":"Hong Y, Hu X, Chen L, Li M, Zhang M, Deng W. Identifying a prognostic signature for clear cell renal cell carcinoma: the convergence of single-cell and bulk sequencing with machine learning. Front Cell Dev Biol. 2025;13:1560095.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"3219_CR84","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289\u201392.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"3219_CR85","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","volume":"15","author":"X Bai","year":"2024","unstructured":"Bai X, Chen Q, Li F, Teng Y, Tang M, Huang J, et al. Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy. Nat Commun. 2024;15(1):6844.","journal-title":"Nat Commun"},{"issue":"8","key":"3219_CR86","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41419-024-06972-4","volume":"15","author":"H Ni","year":"2024","unstructured":"Ni H, Chen M, Dong D, Zhou Y, Cao Y, Ge R, et al. CYLD\/HDAC6 signaling regulates the interplay between epithelial\u2013mesenchymal transition and ciliary homeostasis during pulmonary fibrosis. Cell Death Dis. 2024;15(8):581.","journal-title":"Cell Death Dis"},{"issue":"13_Supplement","key":"3219_CR87","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/1538-7445.AM2018-2162","volume":"78","author":"R Li","year":"2018","unstructured":"Li R, Huang Y, Liu H, Dilger JP, Lin J. Abstract 2162: comparing volatile and intravenous anesthetics in a mouse model of breast cancer metastasis. Cancer Res. 2018;78(13_Supplement):2162.","journal-title":"Cancer Res"},{"issue":"1","key":"3219_CR88","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40364-024-00620-x","volume":"12","author":"H Liu","year":"2024","unstructured":"Liu H, Weng J, Huang CL, Jackson AP. Voltage-gated sodium channels in cancers. Biomark Res. 2024;12(1):70.","journal-title":"Biomark Res"},{"issue":"6","key":"3219_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167844","volume":"1871","author":"H Liu","year":"2025","unstructured":"Liu H, Hamaia SW, Dobson L, Weng J, Hern\u00e1ndez FL, Beaudoin CA, et al. The voltage-gated sodium channel \u03b23 subunit modulates C6 glioma cell motility independently of channel activity. Biochimica et Biophysica Acta (BBA). 2025;1871(6):167844.","journal-title":"Biochimica et Biophysica Acta (BBA)"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03219-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03219-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03219-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:06:20Z","timestamp":1761048380000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03219-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3219"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03219-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1001"}}